CESAR: Center for Substance Abuse Research

Foxy Methoxy

Profile

5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT), also known as Foxy or Foxy Methoxy, is a hallucinogenic drug in the tryptamine family, similar to psilocybin (mushrooms) or psilocin.1 Until recently, Foxy was not a controlled substance. In early April, 2003, the Drug Enforcement Administration temporarily placed Foxy into Schedule I of the 1970 Controlled Substances Act, citing such a placement as “necessary to avoid an imminent hazard to the public safety.” 2 Though Foxy’s use is not widespread, law enforcement agencies identify Foxy as an emerging drug of abuse. They believe that if it is not a scheduled controlled substance, Foxy might appeal to dealers who want to capitalize on the popularity of MDMA (ecstasy) and other club drugs while avoiding the risks of selling those controlled substances.3

Methods of Use

Though available as powder or liquid, Foxy most frequently appears in tablet or capsule form. The tablets are red or purple and often embossed with an alien head or spider stamp. The capsules contain a blue, green, tan, orange, gray, or pink powder.4 Users commonly ingest the pills orally, although users may also smoke or snort the powder.5

Effects of Use

Foxy’s effects are dose-dependent—the larger the dose, the greater the effects.6 Users feel the effects of a 6 to 10 mg dose 20 to 30 minutes after administration. The effects peak at 60 to 90 minutes and last 3 to 6 hours.7

Effects include:
  • Hallucinations
  • Euphoria
  • Empathy
  • Visual and auditory disturbances or distortions
  • Emotional distress
  • Dilated pupils
  • Talkativeness
  • Disinhibition
  • Nausea
  • Vomiting
  • Diarrhea
  • Muscle tension
  • Jaw clenching8
  • Terminology

  • Slang Terms for Foxy Methoxy:
    Fox, Foxy, Foxys, Methoxy Foxy, Trash, Dip foxy, Roxy, Yum Yum, Muffy, Excite-bike, Five9
  • Links

    DEA Intelligence Division: Trippin’ on Tryptamines

    Foot Notes

    1 Drug Enforcement Administration (DEA) Intelligence Division. 2002. Drug Intelligence Brief: Trippin’ on Tryptamines: The Emergence of Foxy and AMT as Drugs of Abuse. October 2002. http://www.usdoj.gov/dea/pubs/intel/02052/02052p.html (Accessed 21 February 2003)
    2 Department of Justice. 2003. 21 CFR Part 1308. Schedule of Controlled Substances: Temporary Placement of alpha-methyltryptamine and 5-methoxy-N, N-diisopropyltryptamine into Schedule I. Federal Register: April 4, 2003.Volume 68. Number 65. http://a257.g.akamaitech.net/7/257/2422/14mar20010800/
    edocket.access.gpo.gov/2003/03-8171.htm (Accessed 25 April 2003)
    3 DEA Intelligence Division. 2002.
    4 DEA Intelligence Division. 2002.
    5 DEA Diversion Control Program. 2003. Scheduling Actions- 2003. FR Doc 03-1800. Federal Register: January 28, 2003. Volume 68, Number 18.http://www.deadiversion.usdoj.gov/fed_regs/sched_actions/2003/fr0128.htm (Accessed 21 February 2003)
    6 DEA Intelligence Division. 2002.
    7 DEA Diversion Control Program. 2003.
    8 DEA Intelligence Division. 2002.
    9 Center for Substance Abuse Research. 2003. The CESAR Foxy Methoxy Web Survey.